


Ribonexus receives €2M in deep tech financing from Bpifrance

Integra Therapeutics closes a new investment of €1.5-million with the addition of Columbus Venture Partners to seed round

Integra Therapeutics appoints recognized geneticist George Church to its Scientific Advisory Board

Univercells acquires SynHelix, entering into synthetic biology and the race to next-generation DNA synthesis
